HTHui Tag

Hui Tag

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Hui Tag has a total of 52 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Healing fractured bones -traditional medicinal plants used by Bodo tribe in Bodoland Territorial Area Districts (BTAD) of Assam, India

    by Jenima Basumatary, Rinchin Norbu Thungon, Pakgam Ngulom Lendo, Pallabi Kalita Hui, Abhaya Prasad Das, Hui Tag

    Background: People of Bodo tribal community are historically reported to be the early settlers of Assam living in the Bodoland Territorial Area Districts (BTAD) region in the Northwestern part of Assam (India) and they have been using plants from their surroundings since the time immemorial for their survival. The present study focused on the medicinal plants used for the treatment of fractured bone by the Bodo people. Methods: Ethnomedicinal data related to utilization of plants for healing fractured bones were collected through semi-structured interviews of the recognised potential informants. The ethnomedicinal metadata collected was quantitatively assessed to determine Relative Frequency of Citation (RFC), Fidelity Level (FL), and Family Importance Value (FIV). Results: This study revealed the fractured bone healing knowledge system of the selected informants of Bodo community of BTAD which include 80 male and 80 female informants (n=160) and most of them were possessing long term experienced in treating fractured bone. The present study recorded the use of 46 plant species belonging to 36 families of which Amaryllidaceae, Solanaceae, Lamiaceae, and Zingiberaceae contributed 3 species each, then these are followed by Fabaceae, Malvaceae, Myrtaceae, Piperaceae, and Vitaceae (2 spp. each) and the remaining families are represented by 1 species each. These plants are dominated by annual herbs (12 spp., 26.67%), Geophytes (9 spp., 20%), trees (9 spp., 20%), shrubs (5 spp., 11.11%), climber (3 spp., 6.52% each), small trees, geophytic-climber, epiphyte, perennial herb and aquatic herb (1 sp., 2.17%) each. The leaf was reported as highest plant part harvested (43.48%), which was followed by bark, fruits, and whole plant (8.70% each), and for 6.52% plants it was stem and rhizome. Highest RFC value (0.13125) was observed for Cissus quadrangularis, followed by Equisetum ramosissimum var. huegelii (0.09375), and Litsea glutinosa (0.06875). Highest FL has been recorded for Crinum asiaticum, Gomphostemma sp., Aloe vera, Gynura nepalensis, Entada rheedei, Hypericum japonicum, Clerodendrum glandulosum, Hibiscus × rosa-sinensis, Moringa oleifera, Syzygium aromaticum, Persicaria hydropiper, Paederia foetida, Datura metel, Bergera koenigii, Nicotiana tabacum, Thelypteris parasitica, and Curcuma aromatica are with 100% each. The family Vitaceae has the highest FIV of 14.38%, followed by Equisetaceae (9.35%), and Zingiberaceae (8.125%). Conclusion: From the study, it has been realized that the native populations of Bodo tribe living in BTAD, Assam is in favor of continuing uses of medicinal plants to treat fractured bones with which they suffer commonly. However, only the elderly people of the Bodo population are culturing and guarding such priceless plant resources and Traditional Knowledge while the younger generation is interested to take modern allopathic way of treatment. It is now important to record the surviving Traditional Knowledge for future scientific evaluation to support the humanity with modern medicines derived from Traditional Knowledge. Keywords: Ethnomedicinal plants, Bodo tribe, Bone fracture, Healing tradition, BTAD, Assam

  • Two new records of Henckelia for India from Arunachal Pradesh

    by Momang Taram, Dipankar Borah, Hui Tag


  • Didymocarpus medogensis (Gesneriaceae): a new record for India

    by Momang Taram, Dipankar Borah, Hui Tag, Anton Weber


  • Identification of phytocompounds from Paris polyphylla Smith as potential inhibitors for HER2 & VEGFR2 cancer genes using molecular docking and molecular dynamics simulation studies

    by Debmalya Das Gupta, Saurov Mahanta, Tanzim Nishad Ullah, Sanjib Kumar Das, Anjini Bellai, Hui Tag, Pallabi Kalita Hui

  • Henckelia arupii (Gesneriaceae): A new species from Arunachal Pradesh, India

    by Momang Taram, Hui Tag

    Henckelia arupii, a new species discovered from Arunachal Pradesh, India, is described and illustrated. The new species is superficially similar to Henckelia adenocalyx and three other Northeast Indian species in habit, in the broadly ovate foliaceous bracts covering the flower buds, in the parallel‐convergent venation of the bracts and in the infundibuliform corolla. However, it differs in having cymes reduced to solitary flowers, a campanulate, narrowly pleated calyx and lanceolate to elliptic revolute calyx segments. A detailed description and photographic illustration of the morphological characters is presented. So far, Henckelia arupii is only known from the type locality.

  • Open Access

    In silico analysis of Bacopa monnieri (L.) Wettst. compounds for drug development against Neurodegenerative Disorders

    by Satyam Sangeet, Arshad Khan, Saurov Mahanta, Nabamita Roy, Sanjib Kumar Das, Yugal Kishore Mohanta, Muthupandian Saravanan, Hui Tag, Pallabi Kalita Hui

    Neurotrophins play a crucial role in the development and regulation of neurons. Alterations in the functioning of these Neurotrophins leads to several Neurodegenerative Disorders. Albeit engineered medications which are accessible for the treatment of Neurodegenerative Disorders, due to their numerous side-effects, it becomes imperative to formulate and synthesize novel drug candidates. Plants could be utilized as an alternative for these manufactured medications because of their low incidental effects in contrast with the engineered drugs. Bacopa monnieri has been traditionally known to be utilized to treat Neurodegenerative Disorders. Therefore, in current study an in-silico based study was carried out to evaluate the pharmacological effect of Bacopa monnieri . Molecular Docking was carried out to screen the active phytochemicals of Bacopa monnieri which can act as potential drug candidates against the causative proteins of Neurodegenerative Disorders. A total of 105 biologically active phytochemicals from Bacopa monnieri were docked against the receptors of brain-derived neurotrophic factor, neurotrophin-3, neurotrophin-4, and nerve growth factor. Based on molecular docking study it was observed that the phytocompounds Vitamin E, Benzene propanoic acid, 3,5-bis(1,1dimethylethyl)4-hydroxy-, methyl ester (BPA), Stigmasterol, and Nonacosane of Bacopa monnieri significantly fits to the active residues of the four selected drug targets. Further Molecular Dynamics simulation study was performed to examine the stability of the binding of these phytochemicals with the selected targets. Drug likeness properties as well as related physico-chemical properties were analyzed through ADMETox study. Our findings suggested that the phytocompounds Vitamin E, BPA, Stigmasterol and Nonacosane significantly bind against brain-derived neurotrophic factor, neurotrophin-3, neurotrophin4, and nerve growth factor, respectively which may be the potential drug candidates for the treatment of neurodegenerative disorders. Graphic


  • Identification of tyrosine kinase inhibitors from Panax bipinnatifidus and Panax pseudoginseng for RTK—HER2 and VEGFR2 receptors, by in silico approach

    by Dipayan Paul, Saurov Mahanta, Hui Tag, Sanjib Kumar Das, Debmalya Das Gupta, Bhaben Tanti, Rajendran Ananthan, Ranjan Das, Sanjay Jambhulkar, Pallabi Kalita Hui

    Breast and stomach cancer is reported as a leading cause for human mortality across the world. The overexpression of receptor tyrosine kinase (RTK) proteins, namely the human epidermal growth factor receptor2 (HER2) and the vascular endothelial growth factor receptor2 (VEGFR2), is reported to be responsible for development and metastasis of breast and stomach cancer. Although several synthetic tyrosine kinase inhibitors (TKIs) as drug candidates targeting RTK—HER2 and VEGFR2 are currently available in the market, these are expensive with the reported side effects. This confers an opportunity for development of alternative novel tyrosine kinase inhibitors (TKIs) for RTK—HER2 and VEGFR2 receptors from the botanical sources. In the present study, we characterized 47 bioactive phytocompounds from the methanol extracts of the rhizomes of Asiatic traditional medicinal herbs—Panax bipinnatifidus and Panax pseudoginseng, of Indian Himalayan landraces using HPLC, GC–MS and high-sensitivity LC–MS tools. We performed molecular docking and molecular dynamics simulation analysis using Schrödinger suite 2020-3 to confirm the TKI phytocompounds showing the best binding affinity towards RTK—HER2 and VEGFR2 receptors. The results of molecular docking studies confirmed that the phytocompound (ligand) luteolin 7-O-glucoside (IHP15) showed the highest binding affinity towards receptor HER2 (PDB ID: 3PP0) with docking score and Glide g score (G-Score) of – 13.272, while chlorogenic acid (IHP12) showed the highest binding affinity towards receptor VEGFR2 (PDB ID: 4AGC) with docking score and Glide g score (G-Score) of – 10.673. Molecular dynamics (MD) simulation analysis carried out for 100 ns has confirmed strong binding interaction between the ligand and receptor complex [luteolin 7-O-glucoside (IHP15) and HER2 (PDB ID: 3PP0)] and is found to be stabilized within 40 to 100 ns of MD simulation, whereas ligand–receptor complex [chlorogenic acid (IPH12) and VEGFR2 (PDB ID: 4AGC)] also showed strong binding interaction and is found to be stabilized within 18–30 ns but slightly deviated during 100 ns of MD simulation. In silico ADME-Tox study using SwissADME revealed that the ligands luteolin 7-O-glucoside (IHP15) and chlorogenic acid (IHP12) have passed majority parameters of the common drug discovery rules. The present study has confirmed luteolin 7-O-glucoside (IHP15) and chlorogenic acid (IHP12) as potential tyrosine kinase inhibitors (TKIs) which were found to inhibit RTKs—HER2 and VEGFR2 receptor proteins, and thus paving the way for development of alternative potential TKIs (drug molecules) for treatment of HER2- and VEGFR2-positive breast and stomach cancer. Graphic abstract


  • Two new species of Henckelia (Gesneriaceae) from the Eastern Himalayan state Arunachal Pradesh, India

    by Momang Taram, Dipankar Borah, Rajeev Kumar Singh, Hui Tag

    Two new species of Henckelia from the Eastern Himalayan state Arunachal Pradesh, India, are described and illustrated. The first, Henckelia dasii Taram, D.Borah, R.Kr.Singh & Tag is allied to H. umbellata Kanthraj & K.N.Nair, the second, H. lallanii Taram, D.Borah, Tag & R.Kr.Singh is close to H. urticifolia (Buch.‐Ham. ex D.Don) A.Dietr. (type species of the former Chirita sect. Chirita). The differences are given in Table 1 and 2, respectively. A key is presented for the 21 Henckelia species presently known from N and NE India.